Fondita European Micro Cap

Morningstar Rating™

The smallest companies albeit the biggest winners in Europe!

The fund

Fondita European Micro Cap is an equity fund that invests in a limited number of small European quality companies with a market capitalisation of up to EUR 800 million. The fund has a concentrated portfolio and invests in companies in the long term, where growth is primarily driven by structural drivers and societal changes.

Micro caps

There is stronger growth and greater potential in Europe’s smallest listed companies. Micro caps in Europe have usually had better growth than large companies over time, which normally results in a better share price development. These companies often have a niche focus, show good profitability, and enjoy a strong market position in their home market.

The fund’s driving forces are changes in the health and well-being of individuals and shifts in consumption behaviour. This also includes digitisation in society, an increased focus on the environment and climate, and the manufacturing industry’s progress towards increasingly automated processes.

The fund invests in micro-companies that have already succeeded in their home market and where we see good growth in the coming years. In the longer term, these companies have the possibility to succeed internationally. 

Sustainability
Read more about the fund’s sustainability principles:
Fund facts

31.8.2022

Fund size (M€)
37,6
ISIN (A)
FI4000242847
ISIN (B)
FI4000242854
Legal structure
UCITS
Currency
EUR
Management fee
2,00 % p.a.
Risk profile
6/7
SFDR Classification
Article 8
Top holdings
Pharmanutra (IT)
6,0 %
Datagroup (DE)
4,8 %
Marlowe (GB)
4,6 %
Medios (DE)
4,5 %
Nexus (DE)
4,4 %
Germany
35 %
Great Britain
15 %
Sweden
13 %
Italy
11 %
Finland
7 %
Return
1 month
-6,6 %
3 months
-10,7 %
6 months
-17,7 %
YTD
-29,9 %
1 year
-29,2 %
3 years
37,6 %
5 years
24,3 %
since launch (7.3.2017)
45,0 %
since launch p.a.
7,0 %
Sector division
Health Care
29 %
Industrials
28 %
Information Technology
20 %
Consumer Staples
8 %
Consumer Discretionary
6 %
Communication Services
4 %
Materials
3 %
Cash
3 %
Top 10 holdings
Pharmanutra (IT)
6,0 %
Datagroup (DE)
4,8 %
Marlowe (GB)
4,6 %
Medios (DE)
4,5 %
Nexus (DE)
4,4 %
Steico (DE)
4,3 %
Coltene Holding (CH)
4,3 %
PharmaSGP Holding (DE)
4,1 %
Focus Entertainment (FR)
3,7 %
Animalcare Group (GB)
3,2 %
Country division
Germany
35 %
Great Britain
15 %
Sweden
13 %
Italy
11 %
Finland
7 %
Switzerland
6 %
France
4 %
Netherlands
2 %
Belgium
2 %
Denmark
1 %
Norway
1 %
Currency exposure
EUR
60 %
GBP
15 %
SEK
13 %
CHF
6 %
DKK
1 %
NOK
1 %
Fees
TER
2,00 %
Subscription fee
0,00 %
Redemption fee
1,00 %

Total client relationship allow for changes in tariff rate.

Documents

FUND INFOMATION
KIID
Fund rules
KIID NO
Prospectus
REPORTS
Monthly report
Annual report
SUSTAINABILITY DOCUMENTS
Responsible Investment Policy
Exclusion list

This is marketing communication. The past performance of the investment fund does not provide any guarantee of future results. Read the fund prospectus and KIID before making any investment decisions. The fund prospectus and KIID are available on English, Finnish and Swedish at our website.

Latest news
Consume and invest responsibly!

In recent days, the media has been flooded with Black Friday campaigns. Ironically, the marketing campaigns for the annual shopping spree started ... Read more

A company with high organic growth

Picture: Alfen One of the fund’s holdings that has made a strong positive contribution to the fund’s return is Alfen. Alfen is a ... Read more

Web design: Wikström Media
Fondita online Fondita
online